-
1
Head and neck squamous cell carcinoma (HNSCC) has a significant survival rate disparity based on disease stage, emphasizing the need for early detection.
-
2
Challenges in developing HNSCC screening tools include low prevalence, heterogeneous disease states, and anatomical inaccessibility of primary sites.
-
3
Multi-cancer early detection (MCED) tests like Galleri analyze circulating cell-free DNA and show promise for early cancer detection across multiple types.
-
4
Real-world data on MCED-identified HNSCC is limited, with only five reported patients, highlighting a gap in clinical experience with this technology.
-
5
This study presents three additional HNSCC cases identified through Galleri testing, contributing to the understanding of MCED's clinical utility.
